
Topic
Formulary Strategy
Tiering, exclusions, preferred products, step therapy, and how access teams prepare the evidence packet.

Pricing & Access· June 6, 2026 · 11 min read

Pricing & Access· June 6, 2026 · 9 min read
CVS Caremark GLP-1 coverage and formulary changes for 2026
By Ran Chen#GLP-1#CVS Caremark#PBM

Pricing & Access· June 6, 2026 · 11 min read
Express Scripts GLP-1 formulary: NPF exclusions, PA criteria, and 2026 coverage rules
By Ran Chen#GLP-1#Express Scripts#Prior Authorization

Approvals· June 2, 2026 · 9 min read
Zaynich (cefepime/zidebactam) access guide: novel AMR antibiotic for resistant cUTI

Pricing & Access· May 31, 2026 · 9 min read
IRA MFP formulary inclusion exception: successor products and plan design

Pricing & Access· May 31, 2026 · 10 min read
MFP-selected drug generic and biosimilar entry monitoring for launch teams

Pricing & Access· May 31, 2026 · 9 min read
Oral GLP-1 launch access checklist: payer team readiness before approval
By Ran Chen#GLP-1#Oral GLP-1#Payer Policy

Pricing & Access· May 31, 2026 · 9 min read
Payer-mandated biosimilar switch communication and nocebo risk
By Ran Chen#Biosimilars#Payer Policy#Formulary Strategy

Pricing & Access· May 31, 2026 · 10 min read
Split-fill specialty pharmacy programs and access friction

Pipeline· May 30, 2026 · 11 min read